AEONNN How It Works Pillars Membership FAQ Journal AEONNNian Access Request Early Access

Supplements for Cellular Energy and Mitochondrial Support

Three compounds have reasonable human evidence, several have good mechanisms and poor bioavailability, and one intervention beats all of them and is free.

7 min read

The Short Answer

Mitochondrial supplementation is a category where mechanism is abundant and human outcome data is scarce, and the gap is mostly a bioavailability problem rather than a biology problem. Several compounds do what the label says inside a cell and never reach the cell at an oral dose. Sorting the category means asking, for each compound, whether the plasma concentration achievable orally resembles the concentration used in the experiment that motivated it.

What Mitochondria Actually Need

Oxidative phosphorylation requires substrate, cofactors, an intact electron transport chain, and functioning quality control that removes damaged mitochondria and builds new ones.

The cofactor requirements are specific and unglamorous. The B vitamins thiamine, riboflavin, niacin, pantothenic acid and biotin are all required at defined steps. Magnesium is required for ATP to be biologically usable, since the active form is magnesium-bound. Iron and sulphur are structural components of the electron transport complexes. Carnitine transports long-chain fatty acids into the matrix. Coenzyme Q10 shuttles electrons between complexes.

The important consequence: if any of these is genuinely short, correcting it can produce a real change in energy metabolism. If none is short, adding more does relatively little, because the pathway is not limited by cofactor availability. That single distinction explains most of the difference between people who notice something from a mitochondrial supplement and people who do not.

The Pillar 1 fundamentals article covers the biology in more depth.

The Compounds With Reasonable Human Evidence

Coenzyme Q10 and ubiquinol. The best-evidenced compound in the category. Trials support benefit in heart failure, and statin-associated muscle symptoms are a common and reasonable use given that statins reduce endogenous synthesis. Ubiquinol, the reduced form, has better absorption; both are fat-soluble and need to be taken with fat. Typical doses run 100 to 200 mg for general use and higher in cardiac contexts. Plasma levels are measurable, which is unusual and useful.

Creatine. Often filed under sports supplements and genuinely a cellular energy compound, buffering ATP through the phosphocreatine system. It has the largest and cleanest evidence base of anything here, and effects extend beyond muscle to cognitive measures under sleep deprivation and metabolic stress. 3 to 5 g daily of monohydrate, no loading required, and it is inexpensive.

L-carnitine and acetyl-L-carnitine. Required for fatty acid transport. Supplementation matters mainly where status is low, which is more likely in older adults, in vegetarians and with certain medications. Acetyl-L-carnitine crosses into the brain better and has trial data on cognitive measures in older adults. Oral bioavailability of L-carnitine is poor, and gut bacteria convert some of it to TMAO, whose cardiovascular significance is debated.

Magnesium. Required for ATP function. Intake is below recommendations in a large fraction of the population, which makes this the most likely genuine shortfall in the list.

The Compounds With Good Mechanisms and Thin Data

CompoundMechanismHuman evidence
PQQReported to promote mitochondrial biogenesis via PGC-1alphaSmall trials; mostly biomarker endpoints
NAD+ precursorsRaise NAD+ for dehydrogenase and sirtuin functionElevation demonstrated; functional benefit inconsistent
Alpha-lipoic acidMitochondrial cofactor and redox cyclingBest evidence in diabetic neuropathy; general use thin
Urolithin APromotes mitophagy; requires gut conversion of ellagitanninsSmall trials with muscle endpoints; encouraging and early
MitoQ and targeted antioxidantsConcentrated in mitochondria by lipophilic cation targetingLimited; mechanistically the most interesting design
ResveratrolProposed sirtuin and PGC-1alpha activationPoor bioavailability; largely disappointing trials
Nicotinamide ribosideNAD+ precursor with clearest regulatory positionElevation reliable; outcomes unresolved

Urolithin A is the most interesting recent entrant because it targets mitophagy, the removal of damaged mitochondria, rather than trying to add capacity. Only some people carry the gut bacteria that convert dietary ellagitannins into it, which is why direct supplementation exists at all, and it is a good example of the microbiome determining who responds to a food-derived compound.

Why the Antioxidant Framing Backfires

Mitochondria produce reactive oxygen species, and the intuitive conclusion, that suppressing them protects mitochondria, turns out to be wrong in an important case.

Reactive oxygen species are signalling molecules as well as damaging ones. Exercise-induced production is part of the signal that drives mitochondrial biogenesis, so blunting it blunts the adaptation. Trials of high-dose vitamin C and vitamin E around training have reported attenuated improvements in insulin sensitivity and in mitochondrial adaptation markers.

The practical rule that follows is specific: high-dose antioxidant supplementation taken close to training may reduce the adaptation you trained for. Food-level antioxidant intake is not the concern, and neither is supplementation taken well away from sessions. This is a timing problem rather than a prohibition.

It also reframes what a mitochondrial supplement should aim at. Supporting biogenesis and mitophagy is a better target than suppressing oxidation, and it is the direction the more thoughtful compounds in the category have moved.

The Intervention That Beats All of Them

Exercise increases mitochondrial density, improves mitochondrial function and enhances mitophagy, with a human evidence base that no compound in this category approaches.

Both endurance work and resistance training contribute, through partly different mechanisms, and the response is dose-dependent across a wide range. Zone 2 volume drives mitochondrial density; higher-intensity work drives further adaptation in the same system.

Two other free interventions are worth naming. Adequate sleep supports mitochondrial function and mitophagy, and sleep restriction impairs both in human studies. Avoiding chronic energy surplus prevents the mitochondrial dysfunction associated with lipid overload in muscle and liver.

This is not a rhetorical point about supplements being useless. It is that the ordering matters, and a person who supplements without training is working on the small variable and leaving the large one alone.

A Defensible Stack

Foundational, if there is reason to think intake is low: magnesium 200 to 400 mg elemental, a B-complex at ordinary doses rather than megadoses, and adequate protein. These correct the cofactor case, which is where a real change is most likely.

Well evidenced regardless: creatine monohydrate 3 to 5 g daily. It is the cheapest and best-evidenced compound in this article.

Situational: CoQ10 or ubiquinol 100 to 200 mg with fat, particularly on a statin or with cardiac indications. Carnitine where status is likely low, which includes older adults and vegetarians.

Experimental, with a defined observation window: one of urolithin A, PQQ or an NAD+ precursor, tried singly for three months against something you can actually measure. Trying all three at once makes attribution impossible for no gain.

Timing note: keep high-dose antioxidants away from training sessions.

What to skip: proprietary mitochondrial blends with a dozen ingredients at undisclosed doses, and anything sold on cell-culture data without a plausible route to that concentration in human tissue.

What to judge it on: perceived energy through the day, training capacity and recovery, and, if you want a harder measure, an estimated cardiorespiratory fitness trend over quarters. Fatigue that does not respond to any of this warrants looking at thyroid function, iron status, sleep-disordered breathing and mood, all of which are more common explanations than mitochondrial dysfunction.

The AEONNN Perspective

Pillar 1 is where AEONNN's Pharmacokinetics layer earns its place in the Matrix. Almost every disappointing mitochondrial supplement has a sound mechanism and an unreachable concentration, and separating those two questions is what keeps a stack honest.

The platform's ordering within this Pillar is cofactor adequacy first, since that is where a genuine shortfall produces a genuine change, then creatine and CoQ10 on their evidence, then one experimental compound at a time with an observation window. The Quality layer matters unusually much here because CoQ10 and urolithin A formulations differ substantially in absorption.

The antioxidant timing conflict is a real cross-Pillar interaction: a Pillar 1 intervention taken close to training can blunt the Pillar 7 adaptation. The Stack Builder handles it as timing rather than exclusion. And the platform states the ordering plainly, that exercise outperforms every compound here, because a stack recommendation that implies otherwise misrepresents the evidence.

Pillar Matrix mapping

Cellular Energy and Repair

Database Matrix layers

  • Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
  • Mechanistic Layer (KEGG, Reactome, UniProt)
  • Pharmacokinetics Layer (HMDB, PubChem)
  • Quality / Formulation Layer (ConsumerLab, Labdoor)

Frequently Asked

What is the best supplement for cellular energy?

Creatine monohydrate at 3 to 5 g daily has the largest and cleanest evidence base, and correcting a genuine magnesium or B-vitamin shortfall produces the largest change where one exists.

Does CoQ10 work?

It has the best trial evidence in the category, with support in heart failure and for statin-associated muscle symptoms. Ubiquinol absorbs better, and both need to be taken with fat.

Do NAD+ precursors improve energy?

They raise NAD+ reliably. Functional benefits in healthy adults are inconsistent across trials, which places them as an experiment with a defined observation window.

What is urolithin A?

A compound produced by gut bacteria from dietary ellagitannins that promotes mitophagy. Only some people carry the converting bacteria, which is why direct supplementation exists.

Can antioxidants harm mitochondrial adaptation?

High-dose vitamin C and E taken close to training have been reported to attenuate improvements in insulin sensitivity and mitochondrial adaptation markers. It is a timing problem rather than a prohibition.

What improves mitochondria most?

Exercise. It increases mitochondrial density and function and enhances mitophagy, with an evidence base no compound in this category approaches. Adequate sleep and avoiding energy surplus follow.

Why do mitochondrial supplements often do nothing?

Either no cofactor was actually short, so the pathway was not limited, or the compound does not reach the concentration in human tissue that the motivating experiment used.

Evidence and review

Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.

Continue Reading

Membership

Reading about cellular Energy and Repair is not the same as knowing where you stand.

AEONNN organizes an article like this one against your own profile. Origin works through Discovered Mode, building your Pillar Matrix from the context you provide. Evolution adds Synched Mode, so supported wearable, Apple Health and laboratory data inform the same reasoning.

AEONNN turns knowledge like this into a protocol that is yours.

Private Early Access opens in August. Public launch follows in September.

By requesting access, you agree to receive AEONNN launch and membership communications. You may unsubscribe at any time. Privacy Policy · Consumer Health Data Privacy Notice

Back to the Journal →